Free Trial

Best Stocks Under $3 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $3.00 (3 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

TuHURA Biosciences stock logo

1. TuHURA Biosciences NASDAQ:HURA

$2.30 -0.13 (-5.35%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$2.35 +0.05 (+2.17%)
As of 08/8/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$100.46 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+450.7% Upside)
Volume
134,145 shares
Average Volume
204,159 shares
Today's Range
$2.29
$2.46
zSpace stock logo

2. zSpace NASDAQ:ZSPC

$2.40 +0.40 (+20.00%)
As of 08/8/2025 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$55.91 million
Consensus Rating
Buy
Consensus Price Target
$15.00 (+525.0% Upside)
Volume
264,255 shares
Average Volume
106,023 shares
Today's Range
$2.05
$2.54
OS Therapies stock logo

3. OS Therapies NYSE:OSTX

$1.73 -0.02 (-1.14%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$1.72 -0.01 (-0.52%)
As of 08/8/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$48.61 million
P/E Ratio
-2.01
Consensus Rating
Buy
Consensus Price Target
$18.00 (+940.5% Upside)
Volume
404,504 shares
Average Volume
738,270 shares
Western Copper & Gold stock logo

4. Western Copper & Gold NYSE:WRN

$1.27 +0.02 (+1.60%)
As of 08/8/2025 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$254.70 million
P/E Ratio
-63.50
Consensus Rating
Buy
Consensus Price Target
$4.00 (+215.0% Upside)
Volume
199,110 shares
Average Volume
362,181 shares
OnKure Therapeutics stock logo

5. OnKure Therapeutics NASDAQ:OKUR

$2.04 +0.03 (+1.49%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$2.03 -0.01 (-0.49%)
As of 08/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$27.56 million
P/E Ratio
-0.39
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,485.0% Upside)
Volume
76,397 shares
Average Volume
74,569 shares
Ovid Therapeutics stock logo

6. Ovid Therapeutics NASDAQ:OVID

$0.51 +0.00 (+0.66%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$0.50 -0.01 (-2.51%)
As of 08/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization
$36.61 million
P/E Ratio
-1.47
Consensus Rating
Buy
Consensus Price Target
$3.10 (+502.1% Upside)
Volume
381,631 shares
Average Volume
2.36 million shares
Quince Therapeutics stock logo

7. Quince Therapeutics NASDAQ:QNCX

$1.65 -0.02 (-1.20%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$1.68 +0.03 (+1.82%)
As of 08/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$88.48 million
P/E Ratio
-1.19
Consensus Rating
Buy
Consensus Price Target
$8.29 (+402.2% Upside)
Volume
188,608 shares
Average Volume
191,987 shares
Reviva Pharmaceuticals stock logo

8. Reviva Pharmaceuticals NASDAQ:RVPH

$0.41 -0.02 (-5.04%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$0.41 +0.00 (+0.22%)
As of 08/8/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$19.54 million
P/E Ratio
-0.52
Consensus Rating
Buy
Consensus Price Target
$9.00 (+2,110.8% Upside)
Volume
1.94 million shares
Average Volume
2.52 million shares
Denison Mine stock logo

9. Denison Mine NYSEAMERICAN:DNN

$2.12 -0.12 (-5.36%)
Closing price 08/8/2025 04:10 PM Eastern
Extended Trading
$2.13 +0.01 (+0.71%)
As of 08/8/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization
$1.90 billion
P/E Ratio
-35.33
Consensus Rating
Buy
Consensus Price Target
$3.00 (+41.5% Upside)
Volume
53.11 million shares
Average Volume
71.07 million shares
Immunic stock logo

10. Immunic NASDAQ:IMUX

$0.87 -0.03 (-3.35%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$0.88 +0.01 (+1.36%)
As of 08/8/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$86.03 million
P/E Ratio
-0.71
Consensus Rating
Buy
Consensus Price Target
$7.50 (+760.0% Upside)
Volume
1.06 million shares
Average Volume
1.12 million shares
HIVE Digital Technologies stock logo

11. HIVE Digital Technologies NASDAQ:HIVE

$2.07 -0.03 (-1.43%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$2.08 +0.02 (+0.72%)
As of 08/8/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital Technologies

Market Capitalization
$474.31 million
P/E Ratio
-5.75
Consensus Rating
Buy
Consensus Price Target
$6.67 (+222.1% Upside)
Volume
9.16 million shares
Average Volume
25.76 million shares
Orchestra BioMed stock logo

12. Orchestra BioMed NASDAQ:OBIO

$2.71 +0.11 (+4.23%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$2.70 -0.01 (-0.41%)
As of 08/8/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Orchestra BioMed Holdings, Inc operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. More about Orchestra BioMed

Market Capitalization
$104.73 million
P/E Ratio
-1.52
Consensus Rating
Buy
Consensus Price Target
$14.00 (+416.6% Upside)
Volume
790,354 shares
Average Volume
340,226 shares
Stardust Power stock logo

13. Stardust Power NASDAQ:SDST

$0.40 +0.00 (+0.20%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$0.40 +0.00 (+0.87%)
As of 08/8/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$24.41 million
P/E Ratio
-0.54
Consensus Rating
Buy
Consensus Price Target
$5.11 (+1,173.3% Upside)
Volume
720,476 shares
Average Volume
23.88 million shares
Lucid Diagnostics stock logo

14. Lucid Diagnostics NASDAQ:LUCD

$1.00 +0.02 (+1.61%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$1.00 +0.01 (+0.84%)
As of 08/8/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid Diagnostics

Market Capitalization
$107.82 million
P/E Ratio
-0.74
Consensus Rating
Buy
Consensus Price Target
$3.55 (+256.2% Upside)
Volume
465,665 shares
Average Volume
844,538 shares
NRx Pharmaceuticals stock logo

15. NRx Pharmaceuticals NASDAQ:NRXP

$2.52 +0.06 (+2.44%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$2.55 +0.03 (+1.19%)
As of 08/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. More about NRx Pharmaceuticals

Market Capitalization
$43.57 million
P/E Ratio
-1.25
Consensus Rating
Buy
Consensus Price Target
$28.50 (+1,031.0% Upside)
Volume
174,461 shares
Average Volume
142,003 shares
Ur Energy stock logo

16. Ur Energy NYSEAMERICAN:URG

$1.22 0.00 (0.00%)
Closing price 08/8/2025 04:10 PM Eastern
Extended Trading
$1.23 +0.01 (+1.15%)
As of 08/8/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$445.09 million
P/E Ratio
-7.18
Consensus Rating
Buy
Consensus Price Target
$2.48 (+102.9% Upside)
Volume
3.17 million shares
Average Volume
5.23 million shares
Mereo BioPharma Group stock logo

17. Mereo BioPharma Group NASDAQ:MREO

$1.53 -0.05 (-3.16%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$1.54 +0.01 (+0.65%)
As of 08/8/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$243.27 million
P/E Ratio
-21.86
Consensus Rating
Buy
Consensus Price Target
$7.20 (+370.6% Upside)
Volume
1.47 million shares
Average Volume
2.08 million shares
FibroBiologics stock logo

18. FibroBiologics NASDAQ:FBLG

$0.58 +0.05 (+9.02%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$0.58 -0.01 (-1.10%)
As of 08/8/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$24.40 million
P/E Ratio
-1.62
Consensus Rating
Buy
Consensus Price Target
$13.00 (+2,132.1% Upside)
Volume
1.01 million shares
Average Volume
537,086 shares
ImmunityBio stock logo

19. ImmunityBio NASDAQ:IBRX

$2.44 +0.04 (+1.67%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$2.43 -0.01 (-0.41%)
As of 08/8/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBio

Market Capitalization
$2.31 billion
P/E Ratio
-5.08
Consensus Rating
Buy
Consensus Price Target
$12.25 (+402.0% Upside)
Volume
4.74 million shares
Average Volume
7.62 million shares
Biomea Fusion stock logo

20. Biomea Fusion NASDAQ:BMEA

$1.54 -0.09 (-5.52%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$1.54 0.00 (0.00%)
As of 08/8/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea Fusion

Market Capitalization
$57.86 million
P/E Ratio
-0.51
Consensus Rating
Buy
Consensus Price Target
$17.00 (+1,003.9% Upside)
Volume
1.08 million shares
Average Volume
828,080 shares
Gain Therapeutics stock logo

21. Gain Therapeutics NASDAQ:GANX

$1.48 -0.01 (-0.67%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$1.57 +0.09 (+6.08%)
As of 08/8/2025 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain Therapeutics

Market Capitalization
$44.50 million
P/E Ratio
-1.72
Consensus Rating
Buy
Consensus Price Target
$8.20 (+454.1% Upside)
Volume
133,249 shares
Average Volume
283,434 shares
FiscalNote stock logo

22. FiscalNote NYSE:NOTE

$0.57 -0.06 (-9.55%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$0.59 +0.02 (+2.95%)
As of 08/8/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FiscalNote Holdings, Inc operates as technology company North America, Europe, Australia, and Asia. It combines artificial intelligence technology, machine learning, and other technologies with analytics, workflow tools, and expert research. More about FiscalNote

Market Capitalization
$90.60 million
P/E Ratio
-1.78
Consensus Rating
Buy
Consensus Price Target
$2.95 (+417.4% Upside)
Volume
3.14 million shares
Average Volume
3.11 million shares
Context Therapeutics stock logo

23. Context Therapeutics NASDAQ:CNTX

$0.72 +0.02 (+2.98%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$0.71 -0.01 (-1.36%)
As of 08/8/2025 06:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context Therapeutics

Market Capitalization
$64.57 million
P/E Ratio
-2.00
Consensus Rating
Buy
Consensus Price Target
$5.25 (+629.4% Upside)
Volume
116,001 shares
Average Volume
202,898 shares
Nuvation Bio stock logo

24. Nuvation Bio NYSE:NUVB

$2.30 -0.04 (-1.71%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$2.32 +0.02 (+0.65%)
As of 08/8/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nuvation Bio Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. More about Nuvation Bio

Market Capitalization
$782.61 million
P/E Ratio
-3.65
Consensus Rating
Buy
Consensus Price Target
$7.33 (+218.8% Upside)
Volume
4.79 million shares
Average Volume
4.25 million shares
Nkarta stock logo

25. Nkarta NASDAQ:NKTX

$1.98 -0.03 (-1.49%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$1.99 +0.01 (+0.51%)
As of 08/8/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about Nkarta

Market Capitalization
$140.50 million
P/E Ratio
-1.31
Consensus Rating
Buy
Consensus Price Target
$14.33 (+623.9% Upside)
Volume
349,055 shares
Average Volume
565,463 shares